NasdaqGM - Delayed Quote USD

Oaktree Acquisition Corp. III Life Sciences (OACCU)

10.61

0.00

(0.00%)

At close: June 9 at 4:00:00 PM EDT

With 59% ownership, Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) boasts of strong institutional backing

Key Insights Institutions' substantial holdings in Oaktree Acquisition III Life Sciences implies that they have...

Simply Wall St. 2 months ago

OACC

OACCU
0.00%

OACCW
Oaktree Acquisition Corp. III Life Sciences Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing December 16, 2024

LOS ANGELES, December 11, 2024--Oaktree Acquisition Corp. III Life Sciences (the "Company") today announced that, commencing December 16, 2024, holders of the units sold in the Company's initial public offering may elect to separately trade the Class A ordinary shares and warrants included in their units. Those units not separated will continue to trade on the Nasdaq Global Market ("Nasdaq") under the symbol "OACCU," and the Class A ordinary shares and warrants that are separated will trade on N

Business Wire 5 months ago

OACCU
0.00%
Oaktree Acquisition Corp. III Life Sciences Announces Pricing of $175 Million Initial Public Offering

LOS ANGELES, October 23, 2024--Oaktree Acquisition Corp. III Life Sciences (the "Company"), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities, priced its initial public offering of 17,500,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market and trade under the ticker symbol "OACCU" beginning on October 24, 2024. Each unit consists of one Class A ordinary share of the Company

Business Wire 7 months ago

OACCU
0.00%

Performance Overview

Return	OACCU	S&P 500 (^GSPC)
YTD	+4.74%	+1.62%
1-Year	+6.10%	+10.00%
3-Year	+6.10%	+59.40%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Oaktree Acquisition Corp. III Life Sciences (OACCU)

With 59% ownership, Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) boasts of strong institutional backing

Oaktree Acquisition Corp. III Life Sciences Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing December 16, 2024

Oaktree Acquisition Corp. III Life Sciences Announces Pricing of $175 Million Initial Public Offering

Performance Overview